Related Experiment Video
Updated: Nov 11, 2025

07:33
In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
35.5K
WNT5a in Colorectal Cancer: Research Progress and Challenges
Guangshun Sun1, Liangliang Wu1, Guoqiang Sun1
1Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Cancer Management and Research
|March 24, 2021
Summary
WNT5a signaling in colorectal cancer influences tumor cell migration and invasion. Understanding this pathway is crucial for developing new therapeutic strategies against this deadly disease.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer remains a significant cause of cancer mortality despite advances in chemotherapy.
- WNT5a is a ligand with dual roles in cancer, potentially inhibiting or promoting tumor growth.
- WNT5a signaling is implicated in colorectal cancer, affecting tumor cell behavior.
Purpose of the Study:
- To review the mechanisms of WNT5a signaling in colorectal cancer.
- To explore the therapeutic potential of targeting WNT5a in colorectal cancer treatment.
Main Methods:
- Literature review of studies on WNT5a in colorectal cancer.
- Analysis of downstream signaling pathways affected by WNT5a.
- Evaluation of WNT5a's role in tumor cell migration and invasion.
Main Results:
- WNT5a activates various downstream pathways in colorectal cancer.
- These pathways primarily impact tumor cell migration and invasion.
- WNT5a's role can be context-dependent, influencing both inhibition and carcinogenesis.
Conclusions:
- WNT5a plays a complex role in colorectal cancer progression.
- Targeting WNT5a signaling presents a potential therapeutic avenue.
- Further understanding of WNT5a mechanisms is vital for effective colorectal cancer management.
Related Concept Videos
Canonical Wnt Signaling Pathway
9.5K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.5K
Non-Canonical Wnt Signaling Pathways
7.8K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.8K
Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K

